Current Fellows

Hadrian Mendoza is a clinical fellow in Hematology/Oncology at Yale-New Haven Hospital. He completed his medical education at Yale University, where he received a Hematology Opportunities for the Next Generation of Research Scholars (HONORS) research grant from the American Society of Hematology to investigate applications of B- and T-cell gene rearrangement analysis in the diagnosis of lymphoid neoplasms. Hadrian completed an internship in Pediatrics at Emory University and Children's Healthcare of Atlanta prior to residency in the Yale Traditional Internal Medicine program. His clinical interests include molecular risk stratification and management of myeloproliferative neoplasms, myelodysplastic syndromes, acute myeloid leukemia, and bone marrow failure syndromes. Hadrian is an avid trumpet player with particular interests in jazz and commercial music. Prior to a career in medicine, he played trumpet and flugelhorn professionally in the Southeast. He has performed and recorded with local and international artists including Lady Gaga, Sam Moore from the soul music duo “Sam & Dave,” Cuban saxophonist Paquito D’Rivera, big band drummer Duffy Jackson, jazz trumpeter and vocalist Joe Gransden, and the Atlanta-based pop/R&B group The Shadowboxers. His original trumpet lines can be heard on "Sabotage" by Wale, from the album Ambition that reached #1 on US Billboard Top R&B/Hip-Hop Albums, #1 on US Billboard top Rap Albums, and #2 on US Billboard 200 in 2011.

I'm Marc, a PGY-1 in internal medicine who ultimately will be training in Heme/Onc as a part of the phsyician-scientist program. Originally an organic chemist in undergrad, I transitioned into cancer cell biology for my PhD. In Neil Ganem's lab we discovered that loss of the Hippo Pathway potently potentiates melanocyte transformation into melanoma even in the absence of oncogenic BRAF signaling as well as what miRNA permit whole-genome doubled cancer cells to escape arrest. Along the way I was fortunate enough to help out with multiple projects ranging from finding new kinases that mediate Hippo pathway signaling (Sanghee Lim's work), what controls cell fate following mitotic slippage (Amanda Bolgioni's work), and finding ways to selectively target whole-genome doubled cancer cells (Ryan Quinton's work).